Driving After Spravato or Ketamine Treatment: Safety Guidelines & Why You Can't
Following ketamine or esketamine, you cannot drive, operate heavy machinery, or engage in tasks requiring complex motor coordination until the next day. The medicine can impact reaction time - the effects of which could pose a risk to yourself and others. This safety protocol protects you during the post-treatment window while acute neuro-cognitive effects fully resolve.
The Pharmacological Reasons Behind Post-Session Regulations
To understand these regulations, it is helpful to look at the underlying neurobiology. Spravato is FDA-approved for adults with treatment-resistant depression and major depression with suicidal thoughts. The active molecule, esketamine, is the S-enantiomer ("The 's' stands for sinistrum, Latin for 'left', as the esketamine molecule is oriented to the left") and is the "more active" component of the racemic compound.
When introduced to the system, the medicine's primary mechanism of action is thought to primarily impact an excitatory chemical in the brain called glutamate, triggering a cascade that aims to reduce depressive symptoms. However, this same pharmacological action acutely alters proprioception, spatial awareness, and reaction times. The brain is entering a biologically receptive window for change, but during the immediate two hours post-administration, cognitive and motor faculties are impacted. Glutamate levels vacillate after treatment, falling, briefly, below baseline. This reduction as well as the general sedation the medicine causes impacts alertness and reaction time. This reduction is the primary reason why treatment centers, like Lumin, engage in treatment only once a person agrees to avoid driving for the remainder of the day after treatment
How Lumin Health Prioritizes Your Physical Safety
At Lumin Health, we view the required clinical can pose not as an inconvenience, but as a critical component of your care protocol. Our Academically-affiliated leadership understands that achieving relief requires self-guided intent, but it also requires an environment of safety.
"The restriction on driving is not merely a bureaucratic hurdle – it is a medical necessity protecting the delicate transition back to baseline. All treatment starts with safety, and not only the safety generated when our staff members and the people we get to see are closely aligned, but also the nuts and bolts safety of making sure that the logistics of care are appropriately tuned to risk." – Dr. Ben Yudkoff, Chief Medical Officer at Lumin Health.
Step-by-Step: The Departure Protocol
The logistical requirements for your departure are maintained to ensure clinical safety. Here is what to expect during your evaluation and subsequent appointments:
- Observation Period: You will remain in our comfortable, monitored environment for a minimum of two hours while vital signs are tracked.
- Medical Clearance: A provider assesses your cognitive baseline, ensuring dizziness, dissociation, and blood pressure changes have fully resolved.
- Arranged Transport: We make sure that you have a safe way home.
- Rest Phase: When getting home, we suggest activities to further decompress and take stock of the experience you just had.
Translating These Rules to Intramuscular Applications
While esketamine is bound by specific Risk Evaluation and Mitigation Strategy protocols, we map the same approach to off-label use of ketamine, such as ketamine for depression.
At Lumin Health, our practice favors IM delivery because it offers a smoother, more comfortable experience compared to a slow intravenous infusion, yet the side effect profiles remain the same. Just as with Spravato, driving after ketamine therapy is explicitly prohibited until after a full night of restful sleep.
Partnering With Your Provider for Optimal Outcomes
The period immediately following your appointment is a prime opportunity psychotherapy or your own self-guided practice. You may find that journaling, light reading, or reflecting on your intent yields profound insights. Meaningful relief may be possible when you pair this biological window with deliberate, self-guided work.
As an organization rooted in Massachusetts but serving as a resource for those seeking clarity nationwide, we understand that coordinating transportation can be challenging. However, we have found that when you plan your travel logistics in advance, you can experience significantly less anxiety entering your sessions. Evidence documented by the American Journal of Psychiatry emphasizes that structured, supervised clinical environments dramatically improve overall tolerability and long-term viability of care.
If you are exploring whether esketamine – administered via the FDA-approved Spravato protocol – or IM racemic injections may be a fit for your specific psychiatric needs, we would be grateful to walk with you towards relief. At Lumin Health, our goal is to provide a meticulously safe setting where you can focus entirely on your path to wellness.
